United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - peumus boldus leaf (unii: q4ewm09m3o) (peumus boldus leaf - unii:q4ewm09m3o), chelidonium majus whole (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), smilax ornata whole (unii: sjo6nf5h81) (smilax ornata whole - unii:sjo6nf5h81), gelsemium sempervirens root (unii: 639kr60q1q) (gelsemium sempervirens root - unii:639kr60q1q), veratrum album root (unii: qns6w5us1z) (veratrum album root - unii:qns6w5us1z), beta vulgaris whole (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), iodine (unii: 9679tc07x4) (iodine - unii:9679tc07x4), lycopodium clavatum spore (unii: c88x29y479) (lycopodium clavatum spore - unii:c88x29y479), strychnos nux-vomica seed (unii: 269xh13919) (strychnos nux-vomica seed - unii:269xh13919), pulsatilla pratensis whole (unii: 8e272251di) (pulsatilla pratensis whole - unii:8e272251di), selenium (unii: h6241uj22b) (selenium - unii:h6241uj22b), thuja occidentalis leafy twig (unii: 1nt28v9397) (thuja occidentalis leafy twig - unii:1nt28v9397), zinc (unii: j41csq7qds) (zinc - unii:j41csq7qds) - beta vulgaris – mucus congestion, boldo – occasional constipation, chelidonium majus - perspiration, ferrum metallicum – nasal discomfort, gelsemium sempervirens - expectoration, iodium – mucus congestion, lycopodium clavatum – bladder discomfort, nux vomica – occasional constipation, pulsatilla (pratensis) - perspiration, sarsaparilla (smilax regelii) – nasal discomfort, selenium metallicum - expectoration, thuja occidentalis – mucus congestion, veratrum album – bladder discomfort, zincum metallicum – occasional constipation • for the temporary relief of symptoms including: • bladder discomfort  • perspiration • expectoration • nasal discomfort • mucus congestion • occasional constipation these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Israel - English - Ministry of Health

bayer israel ltd - interferon beta 1b - powder and solvent for solution for injection - interferon beta 1b 0.3 mg/vial - interferon beta-1b - interferon beta-1b - use in ambulatory patients with relapsing-remitting multiple sclerosis (rrms) and relapsing progressive m.s. to reduce the frequency of clinical exacerbations. treatment of secondary progressive (sp) form of multiple sclerosis. treatment of patients who have experienced a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, including the prescence of mri abnormalities characteristic of m.s. and if they are determined to be at high risk of developing clinically definite multiple sclerosis.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - calcipotriol, quantity: 52.2 microgram/g; betamethasone dipropionate, quantity: 643 microgram/g (equivalent: betamethasone, qty microgram/g) - ointment - excipient ingredients: dl-alpha-tocopherol; oleyl alcohol; liquid paraffin; white soft paraffin - indicated for the once daily topical treatment of plaque-type psoriasis vulgaris amenable to topical therapy.

United States - English - NLM (National Library of Medicine)

prasco laboratories - betamethasone dipropionate (unii: 826y60901u) (betamethasone - unii:9842x06q6m) - betamethasone 0.5 mg in 1 g - augmented betamethasone dipropionate ointment is a corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses in patients 13 years of age or older. augmented betamethasone dipropionate ointment is contraindicated in patients who are hypersensitive to betamethasone dipropionate, to other corticosteroids, or to any ingredient in this preparation. risk summary there are no available data on augmented betamethasone dipropionate ointment use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. observational studies suggest an increased risk of low birthweight infants with the use of greater than 300 grams of potent or very potent topical corticosteroid during a pregnancy. advise pregnant women that augmented betamethasone dipropionate ointment may increase the risk of having a low birthweight infant and to use augmented betamethasone dipropionate ointment on the smallest

United States - English - NLM (National Library of Medicine)

american regent, inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. gastrointesti

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - magnesium orotate (unii: gi96w46m5a) (magnesium orotate - unii:gi96w46m5a), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), pulsatilla vulgaris (unii: i76kb35jev) (pulsatilla vulgaris - unii:i76kb35jev), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), amygdalin (unii - magnesium orotate 12 [hp_x] in 1 ml - temporary relief of symptoms related to vitamin b complex in foods and supplements, including upper respiratory, gastrointestinal, urinary and fatigue. temporary relief of symptoms related to vitamin b complex in foods and supplements, including upper respiratory, gastrointestinal, urinary and fatigue.

United States - English - NLM (National Library of Medicine)

deseret biologicals, inc. - magnesium orotate (unii: gi96w46m5a) (magnesium orotate - unii:gi96w46m5a), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), anhydrous citric acid (unii: xf417d3psl) (anhydrous citric acid - unii:xf417d3psl), cysteine (unii: k848jz4886) (cysteine - unii:k848jz4886), pulsatilla vulgaris (unii: i76kb35jev) (anemone pulsatilla - unii:i76kb35jev), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), amygdalin (unii: - magnesium orotate 12 [hp_x] in 1 ml - temporary relief of symptoms related to vitamin b complex in foods and supplements, including upper respiratory, gastrointestinal, urinary and fatigue. **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), calendula officinalis flowering top (unii: 18e7415pxq) (calendula officinalis flowering top - unii:18e7415pxq), echinacea angustifolia (un - alfalfa 1 [hp_c] in 1 ml - for temporary relief of fatigue, indigesiton, and flatulent colic. for temporary relief of fatigue, indigesiton, and flatulent colic.

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), american ginseng (unii: 8w75vcv53q) (american ginseng - unii:8w75vcv53q), avena sativa flowering top (unii: ma9cqj3f7f) (avena sativa flowering top - unii:ma9cqj3f7f), beta vulgaris (unii: 4g174v5051) (beta vulgaris - unii:4g174v5051), calendula officinalis flowering top (unii: 18e7415pxq) (calendula officinalis flowering top - unii:18e7415pxq), chelidonium majus (unii: 7e889u5rnn) (chelidonium majus - unii:7e889u5rnn), echinacea angustifolia (un - for temporary relief of fatigue, indigestion, and flatulent colic. for temporary relief of fatigue, indigestion, and flatulent colic.

European Union - English - EMA (European Medicines Agency)

bayer ag  - interferon beta-1b - multiple sclerosis - immunostimulants, - betaferon is indicated for the treatment ofpatients with a single demyelinating event with an active inflammatory process, if it is severe enough to warrant treatment with intravenous corticosteroids, if alternative diagnoses have been excluded, and if they are determined to be at high risk of developing clinically definite multiple sclerosis;patients with relapsing-remitting multiple sclerosis and two or more relapses within the last two years;patients with secondary progressive multiple sclerosis with active disease, evidenced by relapses.